FDC Limited Secures U.S.FDA ANDA Approval for Cefixime Oral Suspension
FDC Limited has successfully received ANDA approval from the United States Food and Drug Administration (U.S.FDA). The approval covers Cefixime for Oral Suspension USP.The FDA approval allows the company to market the suspension in two specific strengths: 100 mg / 5 mL and 200 mg / 5 mL. This material development milestone marks a significant achievement for FDC Limited in the pharmaceutical sector.FDC Stock Price Movement
As of 12:20 PM, shares of FDC Limited are slipping by 0.89% in live trading, currently trading at ₹362.90. The stock continues to draw significant attention, with 78,002 shares having been traded in the market thus far.